News From Day 3

The latest data from the ongoing PERCEIVE study seems to be consistent with the findings of clinical trials of voretigene neparvovec (VN), the first approved ocular gene therapy for patients with RPE65-mediated inherited retinal dystrophy and sufficient viable retinal cells. “Based on this year 2 interim analysis, the PERCEIVE study...

Professor Hiroko Terasaki will deliver the Kreissig Award Lecture in Hall 1 (Level 2) at 12:30 on Saturday 3 September 2022. Lecture highlights key questions about retinal mobility and plasticity. The ways in which recent advances in imaging technologies have helped to enhance our understanding of fundamental questions concerning retinal...

A celebration of global ophthalmology  The 5th World Retina Day taking place on September 3 celebrates the scientific exchange of knowledge between retinal specialists from all corners of the globe. “EURETINA is delighted to be able to shine a spotlight on retina developments across the globe. In association with 25...

Catherine Creuzot-Garcher MD, PhD, FEBO will deliver the Gisbert Richard Lecture in Hall 1 (Level 2) at 13:00 on Saturday 3 September 2022.  The principal outcomes and complications of macular surgery is the vast theme of the Gisbert Richard Lecture to be delivered by Catherine Creuzot-Garcher MD, PhD, FEBO at...

Ophthalmologica looks to the next phase of growth Professor Martin Zinkernagel assumed the role of Editor-in-Chief of Ophthalmologica, the official journal of EURETINA, earlier this year. In this interview, he outlines his vision for the journal in the coming years. Has Ophthalmologica achieved its aims in a crowded market for...

Launched as part of EURETINA’s Roadmap 2025 development plan, the Women in Retina (WiR) programme strives to nurture diversity by giving all genders equal opportunity at all levels in the field of retina. In ophthalmology the role played by women is immense with more than 50% of ophthalmologists being female....